Money Talks News on MSN
1 in 4 Medicare patients with dementia get risky drugs. 6 questions families should ask
The memory-care unit wants to calm Mom down with a pill. Before you say yes, there's something they may have skipped.
New research links repeated gabapentin use with increased risk, prompting cautious monitoring for gabapentin and dementia ...
More than 41 million people are living with HIV worldwide, and approximately 570,000 died from AIDS-related illnesses in 2025 ...
AXSM's Auvelity sales surged 54.2% to $333 million in the first half of 2026. New indications could further expand its growth potential.
Spread the loveImagine a world where an Alzheimer’s diagnosis doesn’t automatically mean an inevitable, rapid decline.
Anabolic steroids are synthetic versions of male hormones. Some people who lift weights use them to build muscle faster or ...
What happens after you swallow a statin? Follow its journey through your body and discover the benefits and potential risks ...
Biogen's Q3 earnings are due Oct 28. Explore FY2026 EPS guidance, Alzheimer’s revenue growth, and key risk/reward ...
Arrowhead Pharmaceuticals, Inc. beats on ARO-MAPT with up to 85% CSF tau cut; CNS siRNA platform gains traction. Click for ...
A new Alzheimer's disease prevention study has randomly assigned its first participant to a treatment group — a critical step known as randomization — helping researchers see if Alzheimer’s can be ...
The investigational vaccine targets pathological amyloid-beta to lower brain amyloid in patients with preclinical Alzheimer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results